Reqbio launched the recombinant antibody rapid expression CRO service to meet the needs of early drug discovery and preclinical research. Through the 293/CHO high-throughput transient expression system, expression delivery can be completed within 1 week at the earliest.
At the same time, combined with Reqbio's antibody drug activity screening service platform, the biological activity of the recombinant antibody produced by expression can be tested.
Service Advantage
Fig 1. Antibody Expression Service Advantage
Service flow
Protocol design→gene synthesis→vector construction→cell preparation→rapid expression→affinity purification→delivery after quality control
Service Content
Case presentation
Ordering method
Mail:sales@reqbio.com